You have 9 free searches left this month | for more free features.

Vandetanib

Showing 1 - 25 of 118

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

Recruiting
  • Advanced Malignant Neoplasm
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Cancer, Non Small Cell Lung Cancer Trial in United Kingdom (Vandetanib, Selumetinib)

Completed
  • Cancer
  • Non Small Cell Lung Cancer
  • Vandetanib, Selumetinib
  • Headington, Oxford, United Kingdom
  • +3 more
Sep 9, 2021

Invasive Breast Cancer Trial in Iowa City (Vandetanib, Placebo)

Terminated
  • Invasive Breast Cancer
  • Vandetanib
  • Placebo
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 1, 2021

Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

Not yet recruiting
  • Medullary Thyroid Cancer
  • Cordoba, Spain
  • +1 more
Jan 11, 2023

Metastatic Sporadic Medullary Thyroid Cancer Patients and

Completed
  • Metastatic Sporadic Medullary Thyroid Cancer
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
    Sep 29, 2021

    Carcinoma, Hepatocellular, Metastatic Colorectal Cancer Trial in Bloomsbury (BTG-002814)

    Completed
    • Carcinoma, Hepatocellular
    • Metastatic Colorectal Cancer
    • Bloomsbury, London, United Kingdom
      University College London Hospital
    Jul 15, 2021

    Thyroid Cancer Trial in Worldwide (300mg vandetanib, 150mg vandetanib)

    Active, not recruiting
    • Thyroid Cancer
    • 300mg vandetanib
    • 150mg vandetanib
    • Houston, Texas
    • +25 more
    Oct 20, 2021

    Thyroid Tumors Trial in Worldwide (Vandetanib, Placebo)

    Active, not recruiting
    • Thyroid Neoplasms
    • Vandetanib
    • Placebo
    • Brussels, Belgium
    • +21 more
    Oct 20, 2021

    Renal Cell Carcinoma, Hereditary Leiomyomatosis, Renal Cell Cancer Trial run by the NCI (Vandetanib, Metformin,

    Terminated
    • Renal Cell Carcinoma
    • +2 more
    • Vandetanib
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 12, 2021

    Non Small Cell Lung Cancer Trial in Seoul (Vandetanib)

    Completed
    • Non Small Cell Lung Cancer
    • Vandetanib
    • Seoul, Korea, Republic of
    • +1 more
    Dec 4, 2020

    Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2A, Multiple Endocrine Neoplasia Type 2B Trial run by the NCI

    Completed
    • Medullary Thyroid Carcinoma
    • +2 more
    • Vandetanib
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 1, 2020

    Differentiated Thyroid Cancer Trial in Worldwide (Vandetanib (SAR390530), Placebo)

    Active, not recruiting
    • Differentiated Thyroid Cancer
    • Vandetanib (SAR390530)
    • Placebo
    • Little Rock, Arkansas
    • +60 more
    Oct 20, 2021

    Locally Advanced or Metastatic Medullary Thyroid Cancer, Medullary Thyroid Cancer Trial in Worldwide (Patient outreach,

    Active, not recruiting
    • Locally Advanced or Metastatic Medullary Thyroid Cancer
    • Medullary Thyroid Cancer
    • Patient outreach
    • Vandetanib
    • St Leonards, Australia
    • +33 more
    Oct 20, 2021

    Lip and Oral Cavity Squamous Cell Carcinoma, Oral Cavity Verrucous Carcinoma, Precancerous Condition Trial in Chicago (drug,

    Completed
    • Lip and Oral Cavity Squamous Cell Carcinoma
    • +2 more
    • vandetanib
    • +5 more
    • Chicago, Illinois
      University of Chicago
    Jan 8, 2021

    Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)

    Terminated
    • Thyroid Cancer
    • +5 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jul 12, 2021

    Cancer of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Cancer of the Stomach Trial in Philadelphia

    Completed
    • Cancer of the Esophagus
    • +2 more
    • Vandetanib
    • +4 more
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Jan 4, 2021

    Vandetanib in RET -/+ Metastatic Medullary Thyroid Cancer

    Completed
    • Symptomatic, Aggressive, Sporadic, Unresectable, Locally
    • Advanced/Metastatic Medullary Thyroid Cancer (MTC)
    • Vandetanib 300 mg
    • Belgium, Belgium
    • +7 more
    Oct 15, 2020

    GIST Trial run by the NCI (Vandetanib)

    Completed
    • GIST
    • Vandetanib
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 25, 2020

    Cancer, High-grade Glioma Trial in Amsterdam (Sunitinib, vandetanib, Erlotinib)

    Unknown status
    • Cancer
    • High-grade Glioma
    • Amsterdam, Noord-Holland, Netherlands
      VU University Medical Center
    Oct 6, 2020

    NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)

    Active, not recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Avignon, France
    • +36 more
    Jul 29, 2022

    Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Angers, France
    • +24 more
    Mar 8, 2022

    Non Small Cell Lung Cancer, Lung Cancer Trial in Worldwide (Vandetanib, Pemetrexed)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • Lung Cancer
    • Casa Grande, Arizona
    • +109 more
    Oct 20, 2021

    Relapsed Pediatric Solid Tumor, Refractory Pediatric Solid Tumor, Relapsed Pediatric AML Trial in Seoul (CancerSCAN™,

    Recruiting
    • Relapsed Pediatric Solid Tumor
    • +3 more
    • CancerSCAN™
    • +17 more
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Mar 18, 2020

    Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)

    Recruiting
    • Medullary Thyroid Cancer
    • Birmingham, Alabama
    • +148 more
    Jan 18, 2023

    A Detailed Look At What Patients Experience In Medullary Thyroid

    Not yet recruiting
    • Medullary Thyroid Cancer
      • San Francisco, California
        Power Life Sciences
      Oct 6, 2023